Caroline Dircks
Direttore operativo presso BIOHAVEN LTD.
Provenienza dei contatti di primo grado di Caroline Dircks
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Caroline Dircks tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Adage Capital Management LP
 Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts. | Investment Managers | Analyst-Equity | |
| University of Notre Dame | College/University | Undergraduate Degree Graduate Degree | |
| EVERCORE INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
| ANNEXON, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree | |
| South Dakota State University | College/University | Undergraduate Degree | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree Undergraduate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington Medical Center
 University of Washington Medical Center Other Consumer ServicesConsumer Services University of Washington Medical Center provides healthcare services. It offers gynecology, bariatric, obstetrics, radiology, rehabilitation, neurology, gastric, otolaryngology, ankle, radiology and imaging services. The company was founded on March 1, 1945 and is headquartered in Seattle, WA | College/University | Corporate Officer/Principal | |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment ManagersFinance Surveyor Capital Ltd. is a hedge fund seeding platform headquartered in New York City. The firm was founded in 2008 and is a subsidiary of Citadel LP, which is owned by GFH HFEVA LLC. Surveyor Capital manages capital exclusively for Citadel’s multi-strategy funds and its positions are consolidated in Form 13F filed by Citadel Advisors LLC. | Investment Managers | Portfolio Manager-Equities | |
| The Danish American Chamber of Commerce | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Undergraduate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Compliance Officer Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Investor Relations Contact | |
| Emory University School of Medicine | College/University | Corporate Officer/Principal | |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Miscellaneous Commercial Services | Chairman Chief Operating Officer | |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI. | Pharmaceuticals: Major | Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
Pyramid Biosciences, Inc.
 Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Founder | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV | Financial Conglomerates | Founder | |
| US Green Valley Pharmaceuticals, Inc. | Chief Executive Officer | ||
| PROKIDNEY CORP. | Biotechnology | President | |
| AKILI, INC. | Medical Specialties | Director/Board Member | |
| New York University School of Medicine | College/University | Graduate Degree | |
| The Creighton University School of Medicine | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Danimarca | 2 |
| Irlanda | 2 |
| Canada | 2 |
Settori
| Health Technology | 23 |
| Consumer Services | 15 |
| Finance | 11 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 175 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 48 |
| Chairman | 33 |
| Undergraduate Degree | 29 |
Contatti più connessi
| Insiders | |
|---|---|
| John Childs | 40 |
| Gregory Bailey | 36 |
| David Wurzer | 31 |
| Robert Hugin | 24 |
| Michael Heffernan | 23 |
| Julia Gregory | 22 |
| Irina Antonijevic | 17 |
| Mario David Saltarelli | 17 |
| Nancy E. Stagliano | 15 |
| Kishan Mehta | 15 |
| Vladimir Coric | 14 |
| Matthew Buten | 13 |
| Christine Antalik | 9 |
| Mahalakshmi Radhakrishnan | 9 |
| Mark Day | 8 |
- Borsa valori
- Insiders
- Caroline Dircks
- Connessioni Società
